Wegovy Sales Are Soaring Despite Generic Copycat Drugs
Even though Novo Nordisk warned that copycat versions of its obesity and diabetes drugs would hurt sales in the U.S., second-quarter sales saw a 67% rise year on year. More news covers telehealth company eMed's new CEO; Ascension's new research and development institute; and more.